Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 10/2016

11.05.2016 | Pictorial Essay

Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review

verfasst von: Mustafa M. Haddad, Kenneth W. Merrell, Christopher L. Hallemeier, Geoffrey B. Johnson, Taofic Mounajjed, Kenneth R. Olivier, Jeff L. Fidler, Sudhakar K. Venkatesh

Erschienen in: Abdominal Radiology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Stereotactic body radiation therapy (SBRT) is a noninvasive treatment technique for selected patients with primary liver tumors and liver-confined oligometastatic disease. Recently, SBRT has emerged as an alternative treatment option in non-surgical candidates and in whom percutaneous treatment methods are not possible or contraindicated. The experience with SBRT continues to grow. There are currently no imaging guidelines for assessment of tumor response and follow-up schedule following SBRT. SBRT produces characteristic radiation-induced changes in the treated tumor and surrounding liver parenchyma. Knowledge of these changes is essential in the interpretation of follow-up imaging and assessment of treatment response. In this review, we will describe the CT, MRI, and PET imaging findings following SBRT of both the targeted liver tumor and surrounding hepatic parenchyma.
Literatur
1.
Kirkpatrick JP, Kelsey CR, Palta M, et al. (2014) Stereotactic body radiotherapy: a critical review for nonradiation oncologists. Cancer 120:942–954CrossRefPubMed
2.
Sanuki N, Takeda A, Kunieda E (2014) Role of stereotactic body radiation therapy for hepatocellular carcinoma. World J Gastroenterol 20:3100–3111CrossRefPubMedPubMedCentral
3.
Price TR, Perkins SM, Sandrasegaran K, et al. (2012) Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma. Cancer 118:3191–3198CrossRefPubMed
4.
Olsen CC, Welsh J, Kavanagh BD, et al. (2009) Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 73:1414–1424CrossRefPubMed
5.
Rusthoven KE, Kavanagh BD, Cardenes H, et al. (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27:1572–1578CrossRefPubMed
6.
Swaminath A, Massey C, Brierley JD, et al. (2015) Accumulated delivered dose response of stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys 93:639–648CrossRefPubMed
7.
Sanuki N, Takeda A, Oku Y, et al. (2015) Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma. Hepatol Res 45:540–547CrossRefPubMed
8.
Scorsetti M, Clerici E, Navarria P, et al. (2015) The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly. Br J Radiol 88:20150111CrossRefPubMedPubMedCentral
9.
Scorsetti M, Comito T, Cozzi L, et al. (2015) The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT). J Cancer Res Clin Oncol 141:1301–1309CrossRefPubMed
10.
Huertas A, Baumann AS, Saunier-Kubs F, et al. (2015) Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma. Radiother Oncol 115:211–216CrossRefPubMed
11.
Bujold A, Massey CA, Kim JJ, et al. (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631–1639CrossRefPubMed
12.
Maturen KE, Feng MU, Wasnik AP, et al. (2013) Imaging effects of radiation therapy in the abdomen and pelvis: evaluating “innocent bystander” tissues. Radiographics 33:599–619CrossRefPubMed
13.
Shaffer JL, Osmundson EC, Visser BC, et al. (2015) Stereotactic body radiation therapy and central liver toxicity: a case report. Pract Radiat Oncol 5:282–285CrossRefPubMed
14.
Fajardo LF (1989) The unique physiology of endothelial cells and its implications in radiobiology. Front Radiat Ther Oncol 23:96–112CrossRefPubMed
15.
Fajardo LF, Colby TV (1980) Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 104:584–588PubMed
16.
Shulman HM, McDonald GB, Matthews D, et al. (1980) An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 79:1178–1191PubMed
17.
Sanuki N, Takeda A, Oku Y, et al. (2014) Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients. Acta Oncol 53:399–404CrossRefPubMed
18.
Lall C, Bhargava P, Sandrasegaran K, et al. (2015) Three-dimensional conformal radiation therapy in the liver: MRI findings along a time continuum. J Comput Assist Tomogr 39:356–364PubMed
19.
Schmid-Tannwald C, Strobl FF, Theisen D, et al. (2015) Diffusion-weighted MRI before and after robotic radiosurgery (Cyberknife®) in primary and secondary liver malignancies: a pilot study. Technol Cancer Res Treat 14:191–199PubMed
20.
Eccles CL, Haider EA, Haider MA, et al. (2009) Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations. Acta Oncol 48:1034–1043CrossRefPubMed
21.
Stinauer MA, Diot Q, Westerly DC, et al. (2012) Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases. Int J Radiat Oncol Biol Phys 83:e613–e618CrossRefPubMed
22.
Solanki AA, Weichselbaum RR, Appelbaum D, et al. (2012) The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study. Radiat Oncol 7:216CrossRefPubMedPubMedCentral
23.
Lawrence TS, Robertson JM, Anscher MS, et al. (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31:1237–1248CrossRefPubMed
24.
Howells CC, Stinauer MA, Diot Q, et al. (2012) Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys 84:e441–e446CrossRefPubMed
25.
Dyk P, Weiner A, Badiyan S, et al. (2015) Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child–Pugh score classification system. Pract Radiat Oncol 5:176–182CrossRefPubMed
26.
Yannam GR, Han B, Setoyama K, et al. (2014) A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury. Int J Radiat Oncol Biol Phys 88:404–411CrossRefPubMed
27.
Osmundson EC, Wu Y, Luxton G, et al. (2015) Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract. Int J Radiat Oncol Biol Phys 91:986–994CrossRefPubMed
28.
Reed GB, Cox AJ (1966) The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 48:597–611PubMedPubMedCentral
29.
Sanuki N, Takeda A, Oku Y, et al. (2014) Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA. Int J Radiat Oncol Biol Phys 88:306–311CrossRefPubMed
30.
Kimura T, Takahashi S, Takahashi I, et al. (2015) The time course of dynamic computed tomographic appearance of radiation injury to the cirrhotic liver following stereotactic body radiation therapy for hepatocellular carcinoma. PLoS One 10:e0125231CrossRefPubMedPubMedCentral
31.
Willemart S, Nicaise N, Struyven J, van Gansbeke D (2000) Acute radiation-induced hepatic injury: evaluation by triphasic contrast enhanced helical CT. Br J Radiol 73:544–546CrossRefPubMed
32.
33.
Jarraya H, Borde P, Mirabel X, et al. (2015) Lobulated enhancement evaluation in the follow-up of liver metastases treated by stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 92:292–298CrossRefPubMed
34.
Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60CrossRefPubMed
35.
Chun YS, Vauthey JN, Boonsirikamchai P, et al. (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302:2338–2344CrossRefPubMedPubMedCentral
36.
Choi H, Charnsangavej C, de Castro Faria S, et al. (2004) CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 183:1619–1628CrossRefPubMed
37.
Jarraya H, Mirabel X, Taieb S, et al. (2013) Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking. Radiat Oncol 8:24CrossRefPubMedPubMedCentral
38.
Aitken KL, Hawkins MA (2015) Stereotactic body radiotherapy for liver metastases. Clin Oncol (R Coll Radiol) 27:307–315CrossRef
39.
Aitken K, Tree A, Thomas K, et al. (2015) Initial UK experience of stereotactic body radiotherapy for extracranial oligometastases: can we change the therapeutic paradigm? Clin Oncol (R Coll Radiol) 27:411–419CrossRef
40.
Jarraya H, Chalayer C, Tresch E, et al. (2014) Novel technique for hepatic fiducial marker placement for stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 90:119–125CrossRefPubMed
41.
Oldrini G, Taste-George H, Renard-Oldrini S, et al. (2015) Implantation of fiducial markers in the liver for stereotactic body radiation therapy: feasibility and results. Diagn Interv Imaging 96:589–592CrossRefPubMed
42.
Janoray G (2015) Mornex F [Follow-up after stereotactic body radiation therapy for liver tumours: a review of the literature and recommendations]. Cancer Radiother 19:573–581CrossRefPubMed
43.
Herfarth KK, Hof H, Bahner ML, et al. (2003) Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57:444–451CrossRefPubMed
44.
Hajj C, Goodman KA (2015) Role of radiotherapy and newer techniques in the treatment of GI cancers. J Clin Oncol 33:1737–1744CrossRefPubMed
45.
Oldrini G, Vogin G, Renard-Oldrini S, Taste-George H, Grignon B (2015) Henrot P [Post-therapeutics features of hepatocellular carcinoma treated by stereotactic body radiation therapy]. Presse Med 44:951–953CrossRefPubMed
46.
Richter C, Seco J, Hong TS, Duda DG, Bortfeld T (2014) Radiation-induced changes in hepatocyte-specific Gd-EOB-DTPA enhanced MRI: potential mechanism. Med Hypotheses 83:477–481CrossRefPubMed
47.
Kishan AU, Cao M, Wang PC, et al. (2015) Feasibility of magnetic resonance imaging-guided liver stereotactic body radiation therapy: a comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based intensity modulated radiation therapy. Pract Radiat Oncol 5:330–337CrossRefPubMed
Metadaten
Titel
Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review
verfasst von
Mustafa M. Haddad
Kenneth W. Merrell
Christopher L. Hallemeier
Geoffrey B. Johnson
Taofic Mounajjed
Kenneth R. Olivier
Jeff L. Fidler
Sudhakar K. Venkatesh
Publikationsdatum
11.05.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 10/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0768-x

Weitere Artikel der Ausgabe 10/2016

Abdominal Radiology 10/2016 Zur Ausgabe

Pictorial Essay

Multimodality imaging of fibromuscular dysplasia

OriginalPaper

FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT

OriginalPaper

Diagnostic performance of diffusion-weighted magnetic resonance imaging in differentiating human renal lesions (benignity or malignancy): a meta-analysis

Pictorial Essay

Surgical approaches to chronic pancreatitis: indications and imaging findings

Perspective

Fecal microbiota transplantation via fluoroscopy-guided nasojejunal catheter placement: indications, technique, and the role of radiology

OriginalPaper

18F-FDG PET/CT and primary hepatic MALT: a case series

Neu im Fachgebiet Radiologie

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise